Metropolis Healthcare Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 325.16 | 288.96 | 294.29 |
| Operating Expense | 239.55 | 217.87 | 218.35 |
| Net Profit | 42.26 | 31.28 | 31.78 |
| Net Profit Margin | 13.00 | 10.83 | 10.80 |
| Earning Per Share | 8.24 | 6.11 | 6.20 |
| EBIDTA | 86.14 | 71.50 | 75.70 |
| Effective Tax Rate | 15.35 | 15.26 | 17.16 |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 325.16 |
| Operating Expense | 239.55 |
| Net Profit | 42.26 |
| Net Profit Margin | 13.00 |
| Earning Per Share | 8.24 |
| EBIDTA | 86.14 |
| Effective Tax Rate | 15.35 |
Invest in Metropolis Healthcare Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 1,103.43 | 1,066.04 | 1,157.01 |
| Operating Expenses Annual | 844.94 | 796.73 | 837.65 |
| Operating Profit Annual | 270.48 | 290.59 | 351.41 |
| Interest Annual | 22.34 | 26.69 | 19.60 |
| Depreciation | 75.50 | 70.99 | 49.29 |
| Net Profit Annual | 115.89 | 138.95 | 199.53 |
| Tax Annual | 41.52 | 40.00 | 72.01 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 1,103.43 |
| Operating Expenses Annual | 844.94 |
| Operating Profit Annual | 270.48 |
| Interest Annual | 22.34 |
| Depreciation | 75.50 |
| Net Profit Annual | 115.89 |
| Tax Annual | 41.52 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 24.09 | 27.49 | 347.68 |
| Cash Flow from Operations | 269.01 | 237.74 | 244.04 |
| Cash Flow from Investing | -81.51 | 46.72 | -736.21 |
| Cash Flow from Financing | -183 | -287.87 | 171.97 |
| Cash Flow at the End | 28.59 | 24.09 | 27.49 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 24.09 |
| Cash Flow from Operations | 269.01 |
| Cash Flow from Investing | -81.51 |
| Cash Flow from Financing | -183 |
| Cash Flow at the End | 28.59 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 24.96 | 27.69 | 30.80 |
| PBIT Margin (%) | 16.74 | 19.72 | 25.59 |
| PBT Margin (%) | 16.13 | 19.09 | 24.55 |
| Net PROFIT Margin (%) | 10.50 | 13.03 | 17.25 |
| Return On Networth / Equity (%) | 11.78 | 15.65 | 26.53 |
| Return On Networth /Employed (%) | 15.02 | 17.19 | 29.41 |
| Return On Assets (%) | 9.45 | 11.34 | 19.83 |
| Total Debt / Equity (X) | 0.24 | 0.36 | 0.32 |
| Asset Turnover Ratio (%) | 0.90 | 0.87 | 1.15 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 24.96 |
| PBIT Margin (%) | 16.74 |
| PBT Margin (%) | 16.13 |
| Net PROFIT Margin (%) | 10.50 |
| Return On Networth / Equity (%) | 11.78 |
| Return On Networth /Employed (%) | 15.02 |
| Return On Assets (%) | 9.45 |
| Total Debt / Equity (X) | 0.24 |
| Asset Turnover Ratio (%) | 0.90 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 1,120.09 | 1,085.28 | 1,010.51 |
| Total Current Assets Annual | 272.44 | 265.44 | 353.18 |
| Non Current Assets Annual | 1,200.26 | 1,168.86 | 1,105.36 |
| Total Shareholders Funds Annual | 1,031.19 | 936.02 | 839.21 |
| Total Assets Annual | 1,472.70 | 1,434.29 | 1,458.54 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 1,120.09 |
| Total Current Assets Annual | 272.44 |
| Non Current Assets Annual | 1,200.26 |
| Total Shareholders Funds Annual | 1,031.19 |
| Total Assets Annual | 1,472.70 |
EPS (INR)
Expected
9.08
Reported
9.08
Surprise
0.00%
Jun 2024
EPS beaten by 0.00%
Mar 2024
EPS beaten by 0.14%
Dec 2023
EPS beaten by 0.14%
